Menu
02b-653x337_toraymixin_eaa

Sepsis and septic shock

TORAYMYXIN®

State-of-the-art therapy for patients with endotoxic septic shock

Septic shock is associated with an unacceptable high mortality and a significant economic burden to the sanitary system. Endotoxin is the most potent trigger of the septic cascade and during the progress of sepsis, endotoxin levels can increase up to 1000 fold, even when cultures result negative for Gram-negative bacteria.

Toraymyxin®  Polymyxin B hemoperfusion therapy – from Toray Medical Ltd. (Japan), is the state-of-the-art therapy for endotoxin removal in septic shock patients. More than 150,000 patients have been treated with this innovative therapy and more than 250 peer-reviewed articles have been published, demonstrating the beneficial effects on hemodynamics, organ function and mortality.

EAA™Endotoxin Activity Assay – is the only FDA approved diagnostic assay to detect endotoxin activity in human whole blood. The EAA™ diagnostic test is performed in less than 30 minutes. EAA™ is the diagnostic assay to identify patients with endotoxic septic shock.

chronic-kidney-disease-653x337

Chronic kidney disease

Filtryzer® PMMA

A personalized therapy based on the individual needs of each patient

acute-respiratory-failure-653x337

Acute respiratory failure

ProLUNG®

A minimally invasive extracorporeal CO2 removal system for ventilatory support

Focus on

ISICEM-2018-653x337px

ISICEM 2018 – BRUSSELS

Estor is present at the 38th International Symposium on Intensive Care and Emergency Medicine (ISICEM), 20th – 23rd March 2018, Brussels, Belgium.
Come and meet us at our booth #1.55-56

SRLF_PARIS_2018-653x337px

RÉANIMATION 2018 – PARIS

The Réanimation 2018 meeting organized by the French Intensive Care Society takes place from January 24-26, 2018, at Porte de Versailles in Paris, France.

WorldCOPDday2017-653x337px5

WORLD COPD DAY 2017

World COPD Day on November 15 is organized by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) in collaboration with health care professionals and COPD patient groups throughout the world. It aims to raise awareness about chronic obstructive pulmonary disease (COPD) and improve COPD care throughout the world.